Age and BMI |
m(SD); range |
m(SD);
range |
Age |
71.83 years (±11.14); 24-97 years |
71.83 years (±11.14); 24-97
years |
BMI |
29 (±8.06) |
29 (±8.06) |
Gender |
n (%) |
n (%) |
Men |
71 (59%) |
71 (59%) |
Women |
49 (41%) |
49 (41%) |
Marital Status |
n (%) |
n
(%) |
Married or Partnered |
93 (78%) |
93 (78%) |
Single |
14 (12%) |
14 (12%) |
Widowed |
8 (7%) |
8 (7%) |
Divorced |
6 (5%) |
6 (5%) |
Race |
n (%) |
n (%) |
White/Caucasian |
116 (97%) |
116 (97%) |
Black/African American |
1 (1%) |
1 (1%) |
Hispanic |
2 (2%) |
2 (2%) |
Other |
1 (1%) |
1 (1%) |
Occupational Status |
n (%) |
n
(%) |
Employed |
25 (21%) |
25 (21%) |
Retired or Unemployed |
77 (64%) |
77 (64%) |
Unknown |
18 (15%) |
18 (15%) |
Medical Information |
|
|
AF Type |
n (%) |
n (%) |
Paroxysmal |
90 (75%) |
90 (75%) |
Persistent or Permanent |
28 (23%) |
28 (23%) |
Unsure |
1 (1%) |
1 (1%) |
History of Surgical Intervention for AF |
n (%) |
n (%) |
Ablation |
47 (39%) |
47 (39%) |
Left Atrial Appendage Occlusion |
5 (4%) |
5 (4%) |
Cardioversion |
53 (44%) |
53 (44%) |
Medication Management of AF |
n (%) |
n
(%) |
Anticoagulant |
93 (78%) |
93 (78%) |
Beta-Blocker |
79 (66%) |
79 (66%) |
Calcium Channel Blocker |
12 (10%) |
12 (10%) |
Anti-arrhythmic |
49 (41%) |
49 (41%) |
CHA2DS2VASc Scores |
n
(%) |
n (%) |
0 |
4 (3%) |
4 (3%) |
1 |
21 (18%) |
21 (18%) |
2+ |
95 (79%) |
95 (79%) |
Comorbidities |
n (%) |
n
(%) |
Hypertension |
67 (56%) |
67 (56%) |
Obstructive Sleep Apnea |
45 (38%) |
45 (38%) |
Coronary Artery Disease |
34 (28%) |
34 (28%) |
Congestive Heart Failure |
30 (25%) |
30 (25%) |
Chronic Lung Disease |
29 (24%) |
29 (24%) |
Prior Myocardial Infarction |
16 (13%) |
16 (13%) |
Stroke (TIA/CVA) |
16 (13%) |
16 (13%) |
Diabetes |
14 (12%) |
14 (12%) |
Chronic Kidney Disease |
13 (10.8%) |
13 (10.8%) |
Psychologic and Behavioral Information |
|
|
Alcohol Use |
n (%) |
n (%) |
Mild (1 or less drinks per week) |
26 (34%) |
26 (34%) |
Moderate (7 or less drinks per week) |
33 (43%) |
33
(43%) |
Heavy (8+ drinks per week) |
16 (21%) |
16 (21%) |
Tobacco Use |
n (%) |
n (%) |
Current |
2 (2%) |
2 (2%) |
Prior |
54 (45%) |
54 (45%) |
Never |
64 (53%) |
64 (53%) |
AFEQT Scores |
m (SD) |
m (SD) |
AFEQT Score |
77.43 (±17.46) |
77.43 (±17.46) |
Psychiatric Diagnoses (per chart review) |
n (%) |
n (%) |
Major Depressive Disorder (MDD) |
16 (13%) |
16 (13%) |
Generalized Anxiety Disorder (GAD) |
18 (15%) |
18
(15%) |
PROMIS Measure Scores |
|
|
Domain |
mean raw score rounded (SD) |
T
score |
Physical Function |
17 (3.6) |
43.4 |
Fatigue |
9 (4.0) |
51.0 |
Pain Interference |
6 (2.8) |
52.0 |
Depressive Symptoms |
6 (2.9) |
51.8 |
Anxiety Symptoms |
7 (3.3) |
53.7 |
Social Roles & Activities |
15 (4.4) |
50.0 |
Sleep Disturbance |
9 (3.6) |
48.4 |